Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BORT is a privately held German medical products company focused on orthopaedic aids, braces, supports, orthoses, and medical compression stockings rather than therapeutics or drug development. The company develops, manufactures, and sells a broad portfolio of reimbursable and over-the-counter products for musculoskeletal support, rehabilitation, phlebology, and oedema therapy. Its product families include orthopedic supports and braces, pediatric products, sports supports, and the BORT AktiVen compression line. BORT manufactures most of its products in Germany and operates modern logistics and distribution capabilities from Weinstadt. For a biotech analyst, this is best classified as a commercial medtech/medical device company, not a biotech or pharma pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BORT.